Parameter
| Biomarker | Cyclase - associated protein 2 (CAP2) | Full name | Cyclase-associated protein 2 | Molecular Type | protein |
|---|---|---|---|---|---|
| Molecular Formula | diagnosis | Molecular Weight | Core Functional Dimensions | ||
| Disease | Hepatocellular Carcinoma (HCC) | Disease Subtypes | / | ||
| Organ | Liver | Test Sample / Technology Platform | Tumor tissue/serum (IHC, ELISA) | ||
| Pathobiological Mechanisms | It can regulate cytoskeleton remodeling and promote the migration and invasion of hepatocellular carcinoma cells | ||||
| Clinical Availability Status | Cutting-edge research: in HCC high expression, associated with metastasis potential | ||||
| Notes and Dynamics | Large-scale clinical data are lacking, and further verification is needed | ||||